Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

Health systems preparing Medicare GLP-1 Bridge program focus on staff education, prior authorization, and workflow coordination ahead of July 1 launch.

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of ...

MADISON, Ala. (WAFF) - A new Medicare pilot program launching next month is expected to lower the cost of some GLP-1 weight-loss medications for people who qualify. Under the program, certain GLP-1 ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

When looking out across the competitive GLP-1 landscape, AstraZeneca might not be the first Big Pharma name that comes to mind for many industry watchers. But with a pair of phase 2b readouts at the ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...

A massive wave of new prescriptions for GLP-1 receptor agonists is expected following the July launch of a Medicare pilot program that offers the drugs for weight loss for a flat $50 monthly copay.